To synthesize findings from rodent research examining sex-dependent variability in the effects of classic psychedelics across pharmacokinetics, physiology, neuroplasticity, behavior, and disease models.
Approach:
Literature Review: The review compiles and analyzes existing rodent studies to identify sex differences in the effects of psychedelics.
Key Findings:
Sex differences exist in pharmacodynamics and neurobiological responses to psychedelics.
Females often show stronger or qualitatively distinct behavioral effects compared to males.
Ovarian cycle phase modulates several responses to psychedelics in females.
Divergent therapeutic or adverse outcomes are observed in disease model studies based on sex.
Interpretation:
The evidence indicates that sex is a critical biological variable influencing the neural, physiological, and behavioral effects of psychedelics in rodents.
Limitations:
Most foundational rodent studies have been conducted exclusively in males, limiting understanding of sex-dependent effects.
Single-sex designs in studies do not address the translational relevance of findings across sexes.
Conclusion:
Integrating sex-specific analyses into experimental design is essential for improving translational validity and guiding clinical applications.
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.
